Loading…
XGN
Exagen Inc
NASDAQ· Healthcare· Diagnostics & Research· CUSIP 30068X103
$7.72-9.81%Price as of Oct 17, 12:05 UTC · updated once a day, after the close
At a glance
Exagen Inc (XGN) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Vista, United States and has 216 employees. The company is worth $187.02M. Revenue was $66.58M in fiscal 2025, up 19.7% from the year before. It reported a net loss of $19.95M. The share price is 36.9% below its 52-week high of $12.23. 3 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Two Sigma (Two Sigma Investments), at $278.96K. In that quarter, 1 of them reduced the position. Over the last 30 days, company insiders bought $104.44K and sold $269.79K of its stock on the open market.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $187.02M
- P/E
- —
- Forward P/E
- —
- P/B
- 15.3x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.81
- ROE
- -113.82%
- Profit margin
- -26.61%
- Revenue growth
- +15.90%
- Beta
- 2.12
- 52-week high
- $12.23
- 52-week low
- $2.59
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -24.9% over 5Y.
today you would have $664.37▼ -33.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 7 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Year-end price | $6.08 | $4.10 | $1.99 | $2.40 | $11.63 | $13.20 | $25.40 | |
| P/S | 2.2x | 2.2x | 1.3x | 0.7x | 0.9x | 3.9x | 4.0x | 7.9x |
| P/B | 4.0x | 8.4x | 7.7x | 1.5x | 1.0x | 2.2x | 4.0x | 5.8x |
| EPS |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| INGNInogen Inc | $7.04 | — | 1.1x | 0.00% | -13.14% | $186.83M |
| PEPGPepGen Inc. | $2.70 | — | 1.6x | 0.00% | -75.45% | $186.76M |
| EVMNEvommune, Inc. | $5.17 | — | 0.7x | 0.00% | -52.11% | $187.63M |
| PDEXPro Dex Inc | $58.26 |
About the company
- 216
- Vista, United States